Stocklytics Platform
Asset logo for symbol HOTH
Hoth Therapeutics
HOTH52
$0.85arrow_drop_up2.35%$0.01
Penny Stock
Asset logo for symbol HOTH
HOTH52

$0.85

arrow_drop_up2.35%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Hoth Therapeutics (HOTH) Stocklytics Forecast

According to our analysis, Hoth Therapeutics Inc (HOTH) shows promising potential for future growth. The stock price prediction for HOTH indicates positive trends in the coming years. HOTH is expected to experience significant gains in its stock price, making it an attractive investment option. Machine learning algorithms have also predicted a bullish trend for HOTH, further strengthening our forecast.
In 2023, HOTH's stock price is projected to perform exceptionally well. With a strong market position and innovative products in the pipeline, HOTH is likely to see substantial growth in the next few years. Analysts have set a price target for HOTH, predicting a remarkable increase in stock value by 2023. Their positive outlook aligns with our forecast, making HOTH an appealing investment opportunity.
add Hoth Therapeutics to watchlist

Keep an eye on Hoth Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Hoth Therapeutics (HOTH) stock?

Analysts have set a target price of $10.75 for Hoth Therapeutics (HOTH), based on forecasts from 10 analysts. The predicted price range extends from a high of $33 to a low of $4. This represents a potential increase of up to 3.78K% and a decrease of 370.59% from the current price of $0.85. These forecasts are as of 2019 May 20.
help

What are the analyst ratings for Hoth Therapeutics (HOTH) stock?

Currently, there are no analyst ratings available for Hoth Therapeutics (HOTH), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Hoth Therapeutics (HOTH) stock?

At present, there is no AI or machine-learning-based price prediction available for Hoth Therapeutics (HOTH) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level